Oestrogen receptor gene structure and function in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Oestrogen responsiveness is crucial in breast cancer treatment.
• Mechanisms of acquired resistance to oestrogen and anti-oestrogen therapies are not well-defined.
• Potential causes include altered oestrogen receptor (ER) expression, function, or signaling pathways.

Purpose of the Study:

• To investigate the molecular mechanisms behind the loss of oestrogen responsiveness in breast cancer.
• To examine the role of the oestrogen receptor (ER) gene and its function in acquired hormone resistance.
• To identify specific alterations in ER function that contribute to treatment resistance.

Main Methods:

• Southern analysis of the ER gene in breast tumor biopsies and cell lines.
• Restriction fragment length polymorphism analysis.
• Assessment of ER gene methylation using Hpa II and Msp I digests.
• Development of an in vitro model of oestrogen and anti-oestrogen resistance using MCF-7 cells.
• Gel retardation assays to assess ER DNA binding activity.

Main Results:

• No gross rearrangements or significant amplification of the ER gene were found in most tumors.
• ER gene methylation levels did not correlate with receptor expression.
• In vitro models showed no significant changes in ER gene, mRNA, ligand binding, or progesterone receptor induction.
• Impaired ability of ER to interact with DNA was observed in cells with high resistance.

Conclusions:

• Gross alterations in the oestrogen receptor (ER) gene are not the primary cause of resistance.
• While ER gene methylation varies, it does not directly correlate with ER expression levels.
• The study highlights impaired ER DNA binding as a critical factor in acquired oestrogen and anti-oestrogen resistance in breast cancer.